Nishimura et al., 2015
- Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity.
Frontiers in pharmacology
6:199
Full text @ Front Pharmacol
| Marker Type | Symbol | Name |
|---|---|---|
| Gene | cd151l | CD151 antigen, like |
| Gene | cel.2 | carboxyl ester lipase, tandem duplicate 2 |
| Gene | cp | ceruloplasmin |
| Gene | ednrba | endothelin receptor Ba |
| Gene | f5 | coagulation factor V |
| Gene | fads2 | fatty acid desaturase 2 |
| Gene | fgb | fibrinogen beta chain |
| Gene | gpx1a | glutathione peroxidase 1a |
| Gene | igfbp1a | insulin-like growth factor binding protein 1a |
| Gene | mitfa | melanocyte inducing transcription factor a |
| Gene | rbp4 | retinol binding protein 4, plasma |
| Gene | serpina1l | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1, like |
| Gene | tfa | transferrin-a |
| Gene | tgfbi | transforming growth factor, beta-induced |
| Gene | ucp1 | uncoupling protein 1 |
| Gene | zar1 | zygote arrest 1 |